Cell replacement therapy: Mechanisms of functional recovery

Encyclopedia of Neuroscience

Volumn , Issue , 2009, Pages 643-647

  Dunnett, S B ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052552996     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008045046-9.00007-3     Document Type: Chapter

References (18)

1. Björklund A., Lindvall O., Isacson O., et al. Mechanisms of action of intracerebral neural implants - studies on nigral and striatal grafts to the lesioned striatum. Trends in Neurosciences 1987, 10:509-516.
2. Bohn M.C., Cupit L., Marciano F., Gash D.M. Adrenal grafts enhance recovery of striatal dopaminergic fibers. Science 1987, 237:913-916.
3. Brasted P.J., Watts C., Robbins T.W., Dunnett S.B. Associative plasticity in striatal transplants. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:10524-10529.
4. Cheng H., Cao Y.H., Olson L. Spinal cord repair in adult paraplegic rats - partial restoration of hind-limb function. Science 1996, 273:510-513.
5. David S., Aguayo A.J. Axonal elongation into peripheral nervous system 'bridges' after central nervous system injury in adult rats. Science 1981, 214:931-933.
6. Dunnett S.B., Björklund A. Functional Neural Transplantation 1994, Raven Press, New York.
7. Dunnett S.B., Björklund A. Functional Neural Transplantation II. Novel Cell Therapies for CNS Disorders 2000, Elsevier Science, Amsterdam.
8. Dunnett S.B., Isacson O., Sirinathsinghji D.J.S., Clarke D.J., Björklund A. Striatal grafts in rats with unilateral neostriatal lesions. III. Recovery from dopamine-dependent motor asymmetry and deficits in skilled paw reaching. Neuroscience 1988, 24:813-820.
9. Fawcett J.W., Rosser A.E., Dunnett S.B. Brain Damage, Brain Repair 2001, Oxford University Press, Oxford, NY.
10. Freeman T.B., Widner H. Cell Transplantation for Neurological Disorders 1998, Humana, Totowa, NJ.
11. Krieger D.T., Perlow M.J., Gibson M.J., et al. Brain grafts reverse hypogonadism of gonadotropin releasing hormone deficiency. Nature 1982, 298:468-471.
12. Perlow M.J., Freed W.J., Hoffer B.J., et al. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 1979, 204:643-647.
13. Pluchino S., Furlan R., Martino G. Cell-based remyelinating therapies in multiple sclerosis: Evidence from experimental studies. Current Opinion in Neurology 2004, 17:247-255.
14. Ralph M.R., Foster R.G., Davis F.C., Menaker M. Transplanted suprachiasmatic nucleus determines circadian period. Science 1990, 247:975-978.
15. Sanberg P.R., Wictorin K., Isacson O. Cell Transplantation for Huntington's Disease 1994, R.G. Landes, Austin, TX.
16. Shihabuddin L.S., Palmer T.D., Gage F.H. The search for neural progenitor cells: Prospects for the therapy of neurodegenerative disease. Molecular Medicine Today 1999, 5:474-480.
17. Tan S.A., Aebischer P. The problems of delivering neuroactive molecules to the CNS. Ciba Foundation Symposia 1996, 196:211-236.
18. Winkler C., Kirik D., Björklund A. Cell transplantation in Parkinson's disease: How can we make it work?. Trends in Neurosciences 2005, 28:86-92.